German Anguiano Torres (@gerantomd) header
German Anguiano Torres (@gerantomd) profile picture

Medico Internista, Cardiológo Clínico, Master en Teoría Cardiovascular, FSIAC. Los comentarios vertidos aquí son a título propio

México
Joined March 2010
Photo by German Anguiano Torres (@gerantomd)Photo by German Anguiano Torres (@gerantomd)Photo by German Anguiano Torres (@gerantomd)Photo by German Anguiano Torres (@gerantomd)Photo by German Anguiano Torres (@gerantomd)Photo by German Anguiano Torres (@gerantomd)Photo by German Anguiano Torres (@gerantomd)Photo by German Anguiano Torres (@gerantomd)Photo by German Anguiano Torres (@gerantomd)Photo by German Anguiano Torres (@gerantomd)
German Anguiano Torres retweeted
OPTIMAL-STROKE results presented at #ScientificSessions26 Targeting a systolic BP of less than 120 mm Hg lowered the incidence of major cardiovascular events compared with targeting a systolic BP of less than 140 mm Hg in patients with previous ischemic stroke or transient ischemic attack.
3
25
1
75
2,833
German Anguiano Torres retweeted
Today #AHA26 and @NEJM the 2 big trials of secondary prevention of heart disease with an IL-6 antibody and Lp(a) antisense oligonucleotide. No beneficial effect, overall and across all subgroups nejm.org/doi/full/10.1056/NE… nejm.org/doi/full/10.1056/NE…
25
90
10
306
47,934
German Anguiano Torres retweeted
Lp(a) HORIZON trial: Pelacarsen 80 mg SC monthly yielded similar 4-component MACE rates vs. placebo over a median follow-up of 57 months in patients with established cardiovascular disease and elevated Lp(a), showing neutral effects on cardiovascular outcomes. Download slides here: clinicaltrialresults.org/wp-…
8
33
96
9,876
German Anguiano Torres retweeted
Presented at #ScientificSessions26: In older adults with at least two chronic conditions and no known atherosclerotic cardiovascular disease, statin discontinuation was noninferior to continuation for a composite of myocardial infarction, stroke, or death at 2 years. Full STREAM trial results: nej.md/47U1X9N @AHAScience
36
101
55
395
221,909
German Anguiano Torres retweeted
Presented at #ScientificSessions26: In patients with atherosclerotic cardiovascular disease, chronic kidney disease, and inflammation, ziltivekimab decreased interleukin-6 levels but did not result in fewer cardiovascular events than placebo. Full ZEUS trial results: nej.md/3UCOqQC @AHAScience
7
46
4
116
14,216
German Anguiano Torres retweeted
Presented at #ScientificSessions26: Among patients with cardiovascular disease and high lipoprotein(a) levels, pelacarsen lowered the lipoprotein(a) level, but the risk of major cardiovascular events was similar with pelacarsen and placebo. Full phase 3 Lp(a)HORIZON trial results: nej.md/4AcZL9n @AHAScience
15
112
27
315
41,626
We know elevated Lp(a) marks inherited CV risk. Saturday, HORIZON asks the next question: if we specifically lower Lp(a), do CV outcomes improve? Biomarker --> intervention --> outcome. This one matters. But, what will it tell us? #ScientificSessions26 @AHAScience
🤖 Made with AI
1
7
19
1,179
Can smartwatch AI detect LV dysfunction? WATCH-LV may help answer that Monday. My next question: who receives the signal, acts on it and closes the loop? SIGNAL → WORKFLOW → ACTION → OUTCOME. #ScientificSessions26 @AHAScience
🤖 Made with AI
1
2
50
Obesity trials should not stop at the scale. Monday, SYNCHRONIZE-CVOT asks whether survodutide changes CV outcomes in people with obesity. Weight matters, but health is the outcome I’m watching. #ScientificSessions26 @AHAScience
🤖 Made with AI
1
1
1
72
When might stopping a preventive medicine be reasonable? STREAM studies statin discontinuation in multimorbid older adults without CVD. I’ll be watching time to benefit, function, burden and patient priorities. #ScientificSessions26 @AHAScience
🤖 Made with AI
1
1
2
74
German Anguiano Torres retweeted
No te puedes perder este Consenso Mexicano de Hipertensión 2026 . Súper práctico y útil. grehta.org/formacion-academi… @ANCAM_MEXICO @AncisssteMx @AMPAC2012 @SSalud_mx
2
3
160
German Anguiano Torres retweeted
In this new State-of-the-art paper, the authors review the evidence and guideline support for intracoronary imaging in contemporary clinical practice, and outline a modern, imaging-driven approach to PCI planning. eurointervention.pcronline.c…
3
97
2
256
16,661
German Anguiano Torres retweeted
Cardiogenic shock is associated with high early mortality. Prompt revascularization in infarct-related cardiogenic shock improves outcomes, and mechanical circulatory support may reduce mortality in specific groups. Read the Review Article “Cardiogenic Shock” by Holger Thiele, MD (@thiele_holger), and Christian Hassager, MD, from Heart Center Leipzig at Leipzig University, Leipzig Heart Science, Rigshospitalet, and the University of Copenhagen (@koebenhavns_uni): nej.md/49ohKyV
7
188
4
537
54,304
German Anguiano Torres retweeted
📚Ya está disponible la actualización 2025 de la Guía ESC 2019 sobre el manejo de las dislipemias. 🎯 Actualiza los objetivos terapéuticos 💊 Refuerza y optimiza las estrategias de tratamiento ➡️ Mejora el abordaje integral del riesgo cardiovascular 📄 Puedes descargarla aquí: secardiologia.es/publicacion… @VDelgadoGarcia
4
317
2
1,113
56,074
German Anguiano Torres retweeted
🔥🫀 Inflammation is no longer a hypothesis—it’s a therapeutic target The 2025 ACC Scientific Statement on Inflammation and Cardiovascular Disease marks a turning point: inflammation is now recognized as a causal, measurable, and actionable driver of cardiovascular risk, not just a bystander . 🧠 Key paradigm shift Even in statin-treated patients with optimal LDL-C, residual inflammatory risk—best captured by high-sensitivity C-reactive protein (hsCRP)—strongly predicts recurrent events and cardiovascular death. In fact, post-statin hsCRP is often more prognostic than LDL-C itself. 📏 Measure what you want to treat The statement makes a bold recommendation: 👉 Near-universal hsCRP screening in both primary and secondary prevention. hsCRP <1 mg/L → low risk 1–3 mg/L → intermediate risk 3 mg/L → high inflammatory risk Persistently elevated hsCRP (>2 mg/L) identifies patients who remain vulnerable despite guideline-directed therapy. 💊 Anti-inflammatory therapies: what works (and what doesn’t) ❌ Broad immunosuppression failed (e.g. methotrexate in CIRT). ✅ Targeted inflammation inhibition works: Canakinumab (CANTOS) proved the inflammation hypothesis—reducing events without lowering LDL-C. Low-dose colchicine (0.5 mg/day) reduced recurrent CV events by ~25% and is now FDA-approved for secondary prevention. 🚧 New frontiers: IL-6 inhibition (ziltivekimab, clazakizumab) in CKD, HFpEF, ACS—results expected soon. 🧘‍♂️ Lifestyle is anti-inflammatory medicine Mediterranean/DASH diets 🥗, omega-3 intake 🐟, exercise 🏃‍♀️, weight control, and smoking cessation are explicitly framed as anti-inflammatory interventions, not just “healthy habits.” 🖼️ Imaging: promising, not ready Advanced imaging of vascular inflammation (e.g. perivascular fat attenuation index) is exciting—but not yet for routine clinical use. 🔮 Bottom line Atherosclerosis is an inflammatory disease with lipid involvement. The time has come to treat cholesterol and inflammation—with biomarkers, lifestyle, and targeted therapies—moving cardiovascular prevention into a new era 🚀
15
295
8
853
51,181
German Anguiano Torres retweeted
🆕 Reparación mitral percutánea borde a borde en la insuficiencia mitral secundaria: a quién, cuándo y por qué. 📕 EuroIntervention 🔓 Resumen del artículo en cardioteca.com/hemodinamica-…
11
52
3,491
German Anguiano Torres retweeted
1. Unpaywall — unpaywall . org Extensión para Chrome y Firefox. Identifica versiones gratuitas y legales de artículos científicos en sitios de revistas. Accede al texto completo directamente desde la página del artículo si existe una versión en acceso abierto.
2
4
84
18,998
German Anguiano Torres retweeted
2. Open Access Button (OAB) Plataforma que permite buscar artículos por DOI o URL. Si el documento está disponible en algún repositorio, lo muestra. Además, si no está disponible, te da la opción de solicitarlo directamente al autor. openaccessbutton. org
4
4
65
17,140
German Anguiano Torres retweeted
3. PaperPanda Extensión para navegador (Chrome) que funciona de forma similar a Unpaywall. Detecta DOIs automáticamente en páginas académicas y busca versiones gratuitas. Ideal para estudiantes e investigadores. paperpanda . app
1
1
42
15,431
German Anguiano Torres retweeted
4. DOAJ (Directory of Open Access Journals) Base de datos que indexa más de 20,000 revistas científicas de acceso abierto revisadas por pares. Puedes buscar por tema, título de revista, idioma, etc.
1
4
40
13,666